Cite Filings / OTLK / 0001209191-16-156584
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
3/A

Filing

Outlook Therapeutics, Inc. · Filed 2016-12-22 · Acc 0001209191-16-156584

Documents 1

  • 3/A , xslF345X02/doc3a.xml

Around this filing

  • 2017-09-25 3/A 3/A
  • 2016-12-22 4 CFO and Secretary acquired 50,000 shares (grant or award)
  • 2016-12-22 3/A 3/A
  • 2016-12-22 4 SVP Bus. Strat. & Dev. acquired 30,000 shares (grant or award)
  • 2016-12-22 4 VP, Regulatory Affairs acquired 45,000 shares (grant or award)
  • 2016-12-22 4 SVP, Development & Mfrg acquired 40,000 shares (grant or award)
  • 2016-12-22 4 Chief Medical Officer acquired 50,000 shares (grant or award)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslF345X02/doc3a.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…